A Phase 2 Clinical Study to Evaluate The Efficacy and Safety of ALLO-ASC-SHEET in the Subjects With Diabetic Wagner Grade II Foot Ulcers
Latest Information Update: 28 Aug 2023
At a glance
- Drugs Adipose stem cell therapy Anterogen (Primary)
- Indications Diabetic foot ulcer
- Focus Therapeutic Use
- Sponsors Anterogen
- 23 Aug 2023 Planned End Date changed from 1 Dec 2022 to 1 Jun 2025.
- 23 Aug 2023 Planned primary completion date changed from 1 Jun 2022 to 1 Dec 2024.
- 21 Jan 2021 Status changed from not yet recruiting to recruiting.